Technical Analysis for MSB - Mesoblast limited
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| A | 1.780 | 16.72% | 0.255 |
MSB closed up 16.72 percent on Thursday, November 14, 2024, on 3.87 times normal volume. The bulls were able to push the stock to a new 52-week high. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
Earnings due: Nov 27
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing High | Bullish | 0.00% | |
| Expansion Breakout | Bullish Swing Setup | 0.00% | |
| Pocket Pivot | Bullish Swing Setup | 0.00% | |
| Volume Surge | Other | 0.00% | |
| New 52 Week High | Strength | 0.00% | |
| Upper Bollinger Band Walk | Strength | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Above Upper BB | Strength | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Overbought Stochastic | Strength | 0.00% |
| Alert | Time |
|---|---|
| 5x Volume Pace | about 15 hours ago |
| Possible Pocket Pivot | about 16 hours ago |
| Up 10% | about 16 hours ago |
| Gapped Up (Full) | about 16 hours ago |
| Rose Above Previous Day's High | about 16 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
Mesoblast Limited is engaged in developing cell-based medicines. The Company has leveraged its technology platform, which is based on specialized cells known as mesenchymal lineage adult stem cells, to establish a portfolio of late-stage product candidates. Its allogeneic, off-the-shelf cell product candidates target advanced stages of diseases with high, unmet medical needs, including cardiovascular conditions, orthopedic disorders, immunologic and inflammatory disorders and oncologic/hematologic conditions.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Disease Diseases Life Sciences Biology Disorders Stem Cell Stem Cells Cell Biology Induced Stem Cells
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Disease Diseases Life Sciences Biology Disorders Stem Cell Stem Cells Cell Biology Induced Stem Cells
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 1.83 |
| 52 Week Low | 0.255 |
| Average Volume | 4,026,094 |
| 200-Day Moving Average | 0.946 |
| 50-Day Moving Average | 1.255 |
| 20-Day Moving Average | 1.391 |
| 10-Day Moving Average | 1.423 |
| Average True Range | 0.086 |
| RSI (14) | 78.81 |
| ADX | 36.57 |
| +DI | 51.185 |
| -DI | 9.596 |
| Chandelier Exit (Long, 3 ATRs) | 1.571 |
| Chandelier Exit (Short, 3 ATRs) | 1.514 |
| Upper Bollinger Bands | 1.626 |
| Lower Bollinger Band | 1.155 |
| Percent B (%b) | 1.33 |
| BandWidth | 33.815 |
| MACD Line | 0.076 |
| MACD Signal Line | 0.045 |
| MACD Histogram | 0.0306 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.960 | ||||
| Resistance 3 (R3) | 1.957 | 1.893 | 1.930 | ||
| Resistance 2 (R2) | 1.893 | 1.847 | 1.895 | 1.920 | |
| Resistance 1 (R1) | 1.837 | 1.819 | 1.865 | 1.840 | 1.910 |
| Pivot Point | 1.773 | 1.773 | 1.788 | 1.775 | 1.773 |
| Support 1 (S1) | 1.717 | 1.727 | 1.745 | 1.720 | 1.650 |
| Support 2 (S2) | 1.653 | 1.699 | 1.655 | 1.640 | |
| Support 3 (S3) | 1.597 | 1.653 | 1.630 | ||
| Support 4 (S4) | 1.600 |
